Clinical Trials › NCT05269628
RecruitingPhase 2
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
Sponsored by Tiffany J. Braley, MD, MS
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 166
Target enrollment
1
U.S. states
Mar 2022
Start date
Aug 2027
Expected completion
Interventions / Treatments
Cannabidiol (CBD)Tetrahydrocannabinol (THC)Placebo CBDPlacebo THC
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Michigan1 site
Ann Arbor
MS centers in Michigan
Compare treatment centers near a trial site by center type, providers and trials.
View Michigan centersMore Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.